[Complementary Strategy of RSVpreF Vaccination/Nirsevimab versus Nirsevimab Alone for the Prevention of RSV Infection in Infants in Italy: A Cost-Minimization Analysis]. Farmeconomia. Health Economics and Therapeutic Pathways, [S. l.], v. 26, n. 1, 2025. DOI: 10.7175/fe.v26i1.1583. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/1583. Acesso em: 28 nov. 2025.